A detailed history of First Turn Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, First Turn Management, LLC holds 178,929 shares of BPMC stock, worth $16.8 Million. This represents 2.62% of its overall portfolio holdings.

Number of Shares
178,929
Previous 184,901 3.23%
Holding current value
$16.8 Million
Previous $19.9 Billion 16.95%
% of portfolio
2.62%
Previous 3.24%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$84.1 - $120.5 $502,245 - $719,626
-5,972 Reduced 3.23%
178,929 $16.6 Billion
Q2 2024

Aug 07, 2024

BUY
$85.18 - $108.78 $15.7 Million - $20.1 Million
184,901 New
184,901 $19.9 Billion

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.62B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track First Turn Management, LLC Portfolio

Follow First Turn Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Turn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Turn Management, LLC with notifications on news.